cytarabine has been researched along with fluorexon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campone, M; Le Cabellec, MT; Meflah, K; Oliver, L; Vallette, FM; Vavasseur, F | 1 |
| Albertioni, F; Eriksson, S; Löfgren, C; Månsson, E; Paul, A; Paul, C; Ullberg, K | 1 |
| Asano, S; Chen, MH; Izawa, K; Kobayashi, S; Maruyama, K; Soda, Y; Tani, K; Tojo, A | 1 |
3 other study(ies) available for cytarabine and fluorexon
| Article | Year |
|---|---|
Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Enzyme Activation; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Peptide Hydrolases; Phenotype; Probenecid; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; X-Linked Inhibitor of Apoptosis Protein | 2001 |
Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; Cytarabine; Deoxycytidine Kinase; DNA Fragmentation; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute | 2001 |
A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD7; Biological Transport; Biotinylation; Cell Survival; Chemistry, Pharmaceutical; Cytarabine; Dose-Response Relationship, Drug; Female; Fluoresceins; Fluorescent Dyes; Granulocyte Colony-Stimulating Factor; Humans; Inhibitory Concentration 50; Jurkat Cells; K562 Cells; Leukemia; Lipids; Liposomes; Mice; Mice, Inbred NOD; Mice, SCID; Polyethylene Glycols; Receptors, Granulocyte Colony-Stimulating Factor; Sialic Acid Binding Ig-like Lectin 3; Streptavidin; Technology, Pharmaceutical; Xenograft Model Antitumor Assays | 2013 |